Stryker Non Current Liabilities Total from 2010 to 2024
| SYK Stock | USD 389.71 4.80 1.25% |
Non Current Liabilities Total | First Reported 1985-12-31 | Previous Quarter 12.4 B | Current Value 16 B | Quarterly Volatility 5.1 B |
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0054 or PTB Ratio of 6.37. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
Stryker | Non Current Liabilities Total |
Latest Stryker's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Stryker over the last few years. It is Stryker's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
Stryker Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 8,884,226,667 | |
| Geometric Mean | 4,990,497,696 | |
| Coefficient Of Variation | 59.63 | |
| Mean Deviation | 4,575,878,222 | |
| Median | 8,900,000,000 | |
| Standard Deviation | 5,297,769,805 | |
| Sample Variance | 28066364.9T | |
| Range | 16.2B | |
| R-Value | 0.95 | |
| Mean Square Error | 3148370.5T | |
| R-Squared | 0.90 | |
| Slope | 1,121,224,286 | |
| Total Sum of Squares | 392929108.7T |
Stryker Non Current Liabilities Total History
About Stryker Financial Statements
Stryker investors utilize fundamental indicators, such as Non Current Liabilities Total, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 13.4 B | 14.1 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Stryker Correlation against competitors. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.2 | Dividend Share 3.2 | Earnings Share 9.31 | Revenue Per Share 57.728 | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.